Global Cardiac Marker Market 2025–2029: Unveiling Growth Developments with the Latest Updates
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Cardiac Marker Market Be Worth By 2029?
In recent times, there has been a significant expansion in the size of the cardiac marker market. The predicted growth is from $11.26 billion in 2024 to $12.38 billion in 2025, representing a Compound Annual Growth Rate (CAGR) of 9.9%. Several factors contribute to this growth observed in the historical period, including an increased occurrence of cardiovascular diseases, an aging population coupled with cardiovascular risks, heightened awareness and health screening programs, the incorporation of biomarkers in clinical procedures, and strict regulatory norms and guidelines.
The cardiac marker market is anticipated to witness a significant surge in its size in the coming years. A compound annual growth rate (CAGR) of 12.8% is projected, increasing the market size to $20.05 billion by 2029. Factors contributing to this growth during the forecast period include an increased prevalence of lifestyle-related diseases, advancements in remote monitoring and telemedicine, the development of personalized medicine and precision diagnostics, adoption of point-of-care testing (poct), as well as partnerships and collaborations in the healthcare sector. Future trends that will mark the forecast period range from biomarker discovery and validation, personalized medicine techniques, advancements in assay platform technologies, the incorporation of high-sensitivity troponin tests, and a rise in cardiovascular disease occurrence.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp
What Market Forces Are Contributing To The Growth Of The Cardiac Marker Market?
The escalating occurrence of heart-related ailments is anticipated to drive the expansion of the cardiac marker market in the future. Cardiac diseases consist of various conditions that impact the heart’s structure or function and result in numerous health issues. Cardiac markers play a crucial role in diagnosing and supervising a variety of heart disorders, such as heart attacks, angina, heart failure, and other cardiovascular diseases. As a result, there has been an increased demand for diagnostic tests or cardiac markers. For example, the British Heart Foundation, a UK-based cardiovascular research charity, stated that England had witnessed an increase in coronary heart disease fatalities by 30,000 from the onset of the pandemic until August 2022. Additionally, an unprecedented number of 346,000 individuals were on a cardiac waiting list by the conclusion of August 2022. Therefore, the escalating prevalence of heart-related diseases is expected to spur the growth of the cardiac marker market.
Which Segments Define The Structure Of The Cardiac Marker Market?
The cardiac markermarket covered in this report is segmented –
1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers
2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA
3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications
4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions
Subsegments:
1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits
2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels
3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels
4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels
5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)
What Strategic Shifts And Innovations Are Influencing The Cardiac Marker Market?
The cardiac marker market is increasingly influenced by a major trend of product innovation. Leading players in the market are concentrating on developing innovative solutions in order to fortify their market standing. An exemplar of this is when MiRxes, a biotech firm based in Singapore, approved a microRNA-based diagnostic assessment for the early recognition and diagnostic process of diseases in September 2022. Once this test hits the market, it will complement MiRxes’ existing suite of blood examinations for cancer, providing a broad spectrum of early detection strategies. This move is aimed at mitigating the enlarging clinical and socioeconomic impact of severe diseases, encompassing cancer and cardio-pulmonary conditions.
Which Firms Are Making The Biggest Impact In The Cardiac Marker Market?
Major companies operating in the cardiac marker market include Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, LSI Medience Corporation, Ortho Clinical Diagnostics, DiaSorin, 3M Company, Atom Medical Corporation, Bionet America Inc., Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Abcam plc, General Electric Company
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report
Which Region Is Forecasted To Lead The Cardiac Marker Market In The Coming Years?
North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp
Browse Through More Reports Similar to the Global Cardiac Marker Market 2025, By The Business Research Company
Pacemakers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pacemakers-global-market-report
Cardiac Assist Devices And Equipment Global Market Report 2025
Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
